Premenstrual syndrome (PMS) and its more severe form, premenstrual dysphoric disorder (PMDD), represent conditions that have gradually moved from being observed symptoms to formally recognized mental health disorders. The journey spans nearly two centuries, reflecting evolving medical understanding of the relationship between menstrual cycles and psychological well-being. This article examines the historical progression of how premenstrual conditions have been identified and classified within mental health frameworks, from early 19th century observations to their current status in diagnostic manuals.
Early Recognition of Menstrual-Related Symptoms
The documentation of symptoms associated with the menstrual cycle dates back to the mid-19th century. As early as 1847, Dr. Ernst F. von Feuchtersleben observed that "The menses in sensitive women is almost always attended by mental uneasiness, irritability and sadness." This early observation established a connection between menstruation and psychological symptoms, though it was not yet formally classified as a mental health condition.
The modern terminology for premenstrual conditions began to develop in the early 20th century. Historical records indicate that the term "pre-menstrual tension" was first coined by R.T. Frank in 1931. This represented an initial step toward recognizing the cyclical nature of symptoms related to the menstrual phase. Two decades later, in 1953, Greene & Dalton introduced the term "premenstrual syndrome," expanding the concept beyond mere tension to encompass a broader range of symptoms that women experienced in relation to their menstrual cycles.
Defining and Diagnosing Premenstrual Conditions
Despite early recognition, defining and diagnosing premenstrual conditions has presented significant challenges throughout medical history. The National Institute of Mental Health defines premenstrual changes as "the cyclic occurrence of symptoms that are of sufficient severity to interfere with some aspects of life and which appear with consistent and predictable relationships to menses." This definition requires that symptoms show at least a 30% increase from the intensity measured in the follicular phase (days 5-10 of the menstrual cycle) compared with those measured in the premenstrual phase (the 6 days before menstruation).
Additionally, premenstrual changes must be prospectively documented for at least two consecutive menstrual cycles for formal diagnosis. Some research authorities stipulate a more stringent criterion of a 50% worsening of symptoms by the premenstrual phase. However, the 30% change threshold has been criticized as too liberal and a poor discriminator when comparing women with self-reported severe PMS, women using contraceptives whose natural cyclicity has been suppressed, and women with normal cyclicity who report no premenstrual symptoms.
The Path to Formal Classification in Diagnostic Manuals
The formal classification of premenstrual conditions in psychiatric diagnostic manuals has been a gradual, multi-decade process. The first step toward formal recognition came with the introduction of "late luteal phase dysphoric disorder" (LLPDD) into the DSM-III-R in 1987. This classification appeared under the section headed "Proposed diagnostic categories needing further study," indicating that it was still under consideration for full diagnostic status.
Subsequently, a work group on LLPDD reported to the DSM-IV Task Force, which led to the inclusion of PMDD in DSM-IV (1994) as "premenstrual dysphoric disorder." It appeared in the section "Mood disorders not otherwise specified," with its clinical criteria laid out in Appendix B – "For further study." This placement indicated that while PMDD was recognized as a condition, it was still not fully established as a distinct mental disorder.
The diagnostic criteria for PMDD in DSM-IV required that in most menstrual cycles during the past year, five or more of the following symptoms were present for most of the time during the last week of the luteal phase, began to remit within a few days after the onset of the follicular phase, and were absent in the week post-menses. At least one of the symptoms had to be either:
- Markedly depressed mood, feelings of hopelessness, or self-depreciating thoughts
- Marked anxiety, tension, feeling of being 'keyed up' or 'on edge'
- Marked affective lability (such as mood swings due to feeling overwhelmed or rejected)
These criteria reflected the understanding that PMDD represented a more severe form of premenstrual distress that significantly impacted functioning.
PMDD as a Distinct Mental Disorder in DSM-5
A significant milestone in the recognition of PMDD as a mental health condition occurred with the publication of the DSM-5 in May 2013. In this edition, PMDD was categorized as a distinct mental disorder. This more severe form of premenstrual syndrome has been described as "PMS on steroids" due to its intensity and substantial impact on daily functioning.
PMDD affects between three and eight percent of women, according to PubMed Health. While both PMS and PMDD share physical symptoms such as fatigue, bloating, breast soreness, and disruptions in sleep habits, PMDD is more disabling and severe in its emotional symptoms, including irritability, mood swings, anxiety, or a feeling of hopelessness. For some women who already have underlying depression and anxiety issues, PMDD can intensify these conditions, potentially requiring changes in medication during the second half of their cycle.
Clinical and Cultural Implications of PMDD Classification
The classification of PMDD as a mental disorder in the DSM-5 has had both positive and controversial implications. For some women with the rare disorder, this inclusion has provided validation and a sense of community. However, others have expressed concern about potential repercussions, particularly the possibility of a 'crazy' stigma for women during their menstrual periods.
Legal implications have also been raised, with concerns that PMDD being classified as a mental disorder could affect custody battles or other legal proceedings. For example, as one expert noted, "Say a poor woman was in court, trying to see whether she could keep custody of her child. Her partner's or spouse's attorney might say, 'Yes, your honor, but she has a mental disorder.' And she might not get custody of her children."
The debate surrounding PMDD's classification reflects broader discussions about the medicalization of normal female experiences and the potential for pathologizing women's natural reproductive cycles. Some researchers have questioned the evidence linking emotional states to reproductive function, though they acknowledge that symptoms do exist for many women.
Psychological Understanding and Management Approaches
The psychological understanding of PMS has evolved beyond viewing it as a universal premenstrual performance deficit. Research indicates that work performance is either unaffected or any deficit is either easily compensated for or too subtle for standard testing. However, women with PMS often report more negative interpersonal experiences at work and doubt their competency in the premenstrual phase.
Stereotypical views about how women feel and behave premenstrually may interact with individual psychological factors such as attributional errors, which can influence a woman's subjective experience of her mental and physical state premenstrually. While attributional biases may inflate the reporting of premenstrual symptoms, they do not negate the reality of a patient's distress.
Psychological interventions for PMS broadly subdivide into lifestyle changes such as dietary modifications, relaxation, and exercise programs, and specific therapeutic approaches such as support groups and cognitive-behavioral therapy (CBT). These approaches aim to address both the physical and psychological components of severe PMS, helping women develop coping strategies and symptom management techniques.
The Complexity of PMS Research and Diagnosis
Research on PMS faces inherent challenges due to the multifaceted nature of the condition. As noted in the literature, there are more than 150 symptoms—ranging from psychological, cognitive and neurological to physical and behavioral—attributed to PMS. This broad symptomatology makes it difficult to establish clear boundaries and diagnostic criteria.
Some researchers have expressed skepticism about the extent to which PMS represents a distinct clinical entity rather than a collection of symptoms that may be influenced by various factors. A 2012 study published in Gender Medicine claimed there was very little to no evidence that something like PMS even existed, concluding that "this puzzlingly widespread belief needs challenging, as it perpetuates negative concepts linking female reproduction with negative emotionality." This perspective, while controversial, highlights the ongoing debate in the field about the nature and validity of PMS as a distinct condition.
Clinical Considerations in Diagnosis and Treatment
The assessment and management of patients with severe PMS requires consideration of both physical and psychological components. Clinicians must carefully distinguish between normal premenstrual changes and clinically significant distress. The prospective documentation of symptoms across at least two menstrual cycles remains essential for accurate diagnosis.
For women with PMDD, treatment approaches may include pharmacological interventions, particularly selective serotonin reuptake inhibitors (SSRIs), which have shown efficacy in managing symptoms. Psychological interventions, including cognitive-behavioral therapy, can help women develop coping strategies and address maladaptive thought patterns that may exacerbate symptoms.
It is important to note that for women with comorbid depression and anxiety, PMDD can intensify these conditions, requiring careful management that addresses both the premenstrual exacerbation and the underlying mental health disorder. Treatment may need to be adjusted based on the phase of the menstrual cycle to optimize symptom control.
Conclusion
The identification of PMS and PMDD as mental health issues represents a complex journey spanning nearly two centuries of medical observation, research, and evolving diagnostic frameworks. From early observations of psychological symptoms associated with menstruation in the mid-19th century to the formal recognition of PMDD as a distinct mental disorder in the DSM-5 in 2013, our understanding of these conditions has progressively deepened.
The classification of PMDD in the DSM-5 has provided formal recognition for a condition that significantly impairs daily functioning for a small percentage of women. However, this classification has also sparked important discussions about the medicalization of normal female experiences, potential stigma, and the need for careful diagnosis that distinguishes between normal premenstrual changes and clinically significant distress.
As research continues to refine our understanding of PMS and PMDD, it is essential to balance clinical recognition with sensitivity to the broader cultural and social implications of these classifications. The evolution of these conditions in mental health diagnosis reflects not only scientific progress but also changing perspectives on women's health and the intersection of biology, psychology, and society.